JP6285972B2 - Ａｃｙ−１の虚血／再灌流、移植片機能発現遅延及び移植片バイアビリティーのマーカーとしての使用及びその方法 - Google Patents

Ａｃｙ−１の虚血／再灌流、移植片機能発現遅延及び移植片バイアビリティーのマーカーとしての使用及びその方法 Download PDF

Info

Publication number
JP6285972B2
JP6285972B2 JP2015562318A JP2015562318A JP6285972B2 JP 6285972 B2 JP6285972 B2 JP 6285972B2 JP 2015562318 A JP2015562318 A JP 2015562318A JP 2015562318 A JP2015562318 A JP 2015562318A JP 6285972 B2 JP6285972 B2 JP 6285972B2
Authority
JP
Japan
Prior art keywords
acy
patient
dgf
sample
transplantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015562318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512325A (ja
JP2016512325A5 (cg-RX-API-DMAC10.html
Inventor
エリザベス バンクス ロザモンド
エリザベス バンクス ロザモンド
ピーター ウェルベリー スミス マシュー
ピーター ウェルベリー スミス マシュー
ジョン セルビー ピーター
ジョン セルビー ピーター
ルイントン アンドリュー
ルイントン アンドリュー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leeds
Original Assignee
University of Leeds
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leeds filed Critical University of Leeds
Publication of JP2016512325A publication Critical patent/JP2016512325A/ja
Publication of JP2016512325A5 publication Critical patent/JP2016512325A5/ja
Application granted granted Critical
Publication of JP6285972B2 publication Critical patent/JP6285972B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7019—Ischaemia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2015562318A 2013-03-13 2014-03-13 Ａｃｙ−１の虚血／再灌流、移植片機能発現遅延及び移植片バイアビリティーのマーカーとしての使用及びその方法 Expired - Fee Related JP6285972B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1304460.7A GB201304460D0 (en) 2013-03-13 2013-03-13 Biomarker
GB1304460.7 2013-03-13
PCT/GB2014/050768 WO2014140595A1 (en) 2013-03-13 2014-03-13 Use of acy-1 as a marker of ischaemia/reperfusion, delayed graft function and graft viability as well as method thereof

Publications (3)

Publication Number Publication Date
JP2016512325A JP2016512325A (ja) 2016-04-25
JP2016512325A5 JP2016512325A5 (cg-RX-API-DMAC10.html) 2017-04-20
JP6285972B2 true JP6285972B2 (ja) 2018-02-28

Family

ID=48189800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015562318A Expired - Fee Related JP6285972B2 (ja) 2013-03-13 2014-03-13 Ａｃｙ−１の虚血／再灌流、移植片機能発現遅延及び移植片バイアビリティーのマーカーとしての使用及びその方法

Country Status (6)

Country Link
US (1) US10184941B2 (cg-RX-API-DMAC10.html)
EP (1) EP2972384B1 (cg-RX-API-DMAC10.html)
JP (1) JP6285972B2 (cg-RX-API-DMAC10.html)
CN (1) CN105051543A (cg-RX-API-DMAC10.html)
GB (1) GB201304460D0 (cg-RX-API-DMAC10.html)
WO (1) WO2014140595A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3789765A1 (en) * 2019-09-09 2021-03-10 ETH Zürich A method for evaluating damage of solid tissue
CN115109767B (zh) * 2020-02-12 2023-07-25 青岛农业大学 一种氨基酰化酶-1提高细菌抗聚乙二醇能力的方法和用途
US20220241028A1 (en) * 2021-01-22 2022-08-04 Ethicon Llc Prediction of blood perfusion difficulties based on biomarker monitoring
WO2024076485A1 (en) * 2022-10-06 2024-04-11 Natera, Inc. Nucleic acid analysis of perfusion or flush fluids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2892171B2 (ja) * 1991-03-22 1999-05-17 寳酒造株式会社 ポリペプチド
US7262017B2 (en) 2001-09-14 2007-08-28 Torrey Pines Institute For Molecular Studies Diagnostic markers for ischemia
US8741557B2 (en) * 2003-02-14 2014-06-03 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
JPWO2008032868A1 (ja) 2006-09-15 2010-01-28 株式会社島津製作所 腎癌の腫瘍マーカー及び腎癌の罹患の識別方法
EP2131200A1 (en) 2008-06-04 2009-12-09 BRAHMS Aktiengesellschaft A marker for graft failure and mortality
FR2933773B1 (fr) * 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
US9938579B2 (en) 2009-01-15 2018-04-10 The Board Of Trustees Of The Leland Stanford Junior University Biomarker panel for diagnosis and prediction of graft rejection
ES2356217B1 (es) 2009-08-04 2012-02-13 Universidad De Salamanca Método para la detección de daño renal.

Also Published As

Publication number Publication date
GB201304460D0 (en) 2013-04-24
WO2014140595A1 (en) 2014-09-18
EP2972384A1 (en) 2016-01-20
CN105051543A (zh) 2015-11-11
US20160033507A1 (en) 2016-02-04
US10184941B2 (en) 2019-01-22
JP2016512325A (ja) 2016-04-25
EP2972384B1 (en) 2017-07-26

Similar Documents

Publication Publication Date Title
Vilades et al. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker
US8039227B2 (en) Peptide biomarkers predictive of renal function decline and kidney disease
ES2891347T3 (es) Métodos para diagnosticar y evaluar la esteatohepatitis no alcohólica
US9638701B2 (en) Method to determine treatment of acute heart failure
EP2281203B1 (en) A marker for graft failure and mortality
JP2015519564A (ja) 子癇前症評価を提供するための方法および組成物
EP2506016A2 (en) Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker
US20160245826A1 (en) Ltbp2 as a biomarker for renal dysfunction
JP2014525593A (ja) 心臓血管リスクを予測するための診断分析
Roehm et al. Novel biomarkers of kidney disease in advanced heart failure: beyond GFR and proteinuria
Konvalinka et al. Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring
TWI429752B (zh) 不健康細胞之偵測方法及其應用
Salem et al. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes
JP2016512325A (ja) Ａｃｙ−１の虚血／再灌流、移植片機能発現遅延及び移植片バイアビリティーのマーカーとしての使用及びその方法
Abdallah et al. Novel troponin-like biomarkers of acute kidney injury
Bai et al. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children
US20200064344A1 (en) Use of serum 2-cysteine peroxiredoxins (2-cys-prdx) as biomarkers of chronic kidney diseases
US8728984B2 (en) Acute kidney injury risk testing
Batko et al. Predicting long-term kidney graft failure using novel multi-omic blood-based biomarkers and artificial intelligence tools
CN110678757A (zh) 诊断或监测肾功能或诊断肾功能障碍的方法
EP2882767B1 (en) Evaluating renal injury using hyaluronic acid
US20150064715A1 (en) Urinary biomarkers of renal and mitochondrial dysfunction

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170313

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170313

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20171213

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180202

R150 Certificate of patent or registration of utility model

Ref document number: 6285972

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees